Literature DB >> 21122605

Hormonal contraceptive practices in young Australian women (≤ 25 years) and their possible impact on menstrual frequency and iron requirements.

Alecia J Greig1, Michelle A Palmer, Lynne M Chepulis.   

Abstract

OBJECTIVES: To investigate the hormonal contraceptive practices of female university students aged ≤ 25 years, their menstrual bleeding frequency, and interest in contraceptive regimens that reduce menstrual frequency or duration. STUDY
DESIGN: A 20-item questionnaire was distributed to female students at Griffith University, Gold Coast campus. This included questions relating to: demographics, menstrual bleeding frequency, current contraceptive practices, and interest in future oral contraceptive regimens that reduce menstrual bleeding frequency and duration. MAIN OUTCOME MEASURES: Determination of hormonal contraceptive practices and menstrual bleeding frequency undertaken by the sample population.
RESULTS: Eight hundred and fifty one participants completed the questionnaire, ~ 2/3rds of respondents are currently using a hormonal contraceptive (66% of all respondents), with the oral contraceptive pill (OCP) being most common. Most women (73%) reported monthly menstruation, although 16% indicated that they sometimes missed their monthly period, with bleeding every two months. Of all OCP users, approximately 2/3rds have skipped their monthly period at some time, the most common reasons being for convenience (89%). Approximately 70% of respondents were interested in OCP regimens that reduced frequency or duration of menstruation.
CONCLUSION: OCP use is popular amongst Australian university women, with many being interested in the concept of using the OCP to delay menstruation. Given this interest and the availability of hormonal contraceptives that reduce menstrual frequency and duration, assessing the impact of reduced menstrual blood loss on iron stores may be warranted.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21122605     DOI: 10.1016/j.srhc.2010.06.001

Source DB:  PubMed          Journal:  Sex Reprod Healthc        ISSN: 1877-5756


  6 in total

1.  Menstrual Irregularity, Hormonal Contraceptive Use, and Bone Stress Injuries in Collegiate Female Athletes in the United States.

Authors:  Jennifer Cheng; Kristen A Santiago; Zafir Abutalib; Kate E Temme; Ann Hulme; Marci A Goolsby; Carrie L Esopenko; Ellen K Casey
Journal:  PM R       Date:  2020-12-19       Impact factor: 2.298

2.  Characteristics of scheduled bleeding manipulation with combined hormonal contraception in university students.

Authors:  Hannah Lakehomer; Paul F Kaplan; David G Wozniak; Christopher T Minson
Journal:  Contraception       Date:  2013-01-08       Impact factor: 3.375

3.  Joint Model of Iron and Hepcidin During the Menstrual Cycle in Healthy Women.

Authors:  Adeline Angeli; Fabrice Lainé; Audrey Lavenu; Martine Ropert; Karine Lacut; Valérie Gissot; Sylvie Sacher-Huvelin; Caroline Jezequel; Aline Moignet; Bruno Laviolle; Emmanuelle Comets
Journal:  AAPS J       Date:  2016-02-02       Impact factor: 4.009

4.  Hormonal contraception increases risk of asthma among obese but decreases it among nonobese subjects: a prospective, population-based cohort study.

Authors:  Melanie C Matheson; John A Burgess; Melisa Y Z Lau; Adrian J Lowe; Lyle C Gurrin; John L Hopper; Graham G Giles; David P Johns; E Haydn Walters; Michael J Abramson; Francisco Gómez Real; Shyamali C Dharmage
Journal:  ERJ Open Res       Date:  2015-11-03

Review 5.  There might be blood: a scoping review on women's responses to contraceptive-induced menstrual bleeding changes.

Authors:  Chelsea B Polis; Rubina Hussain; Amanda Berry
Journal:  Reprod Health       Date:  2018-06-26       Impact factor: 3.223

6.  A simple and feasible questionnaire to estimate menstrual blood loss: relationship with hematological and gynecological parameters in young women.

Authors:  Laura Toxqui; Ana M Pérez-Granados; Ruth Blanco-Rojo; Ione Wright; M Pilar Vaquero
Journal:  BMC Womens Health       Date:  2014-05-30       Impact factor: 2.809

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.